As the U.S. IPO market opens back up, here’s how biotech CEO Marc de Garidel says business leaders can capitalize.
The impact of IL10 mutation in birds highlights the intrinsic compromise between effective elimination of a pathogen and damage to the host.
ALISO VIEJO, Calif., October 14, 2025--indie (Nasdaq: INDI), an automotive solutions innovator, has released a new Visible ...
Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.